NCT06733974

Brief Summary

In France, a study has reported that about 0.2% of patients visiting the ED died in the ED. A large survey of 145 EDs in 3 French speaking countries has reported that a median of 2 patients dies each week in each ED and its observation unit. After the death of a loved one, prolonged grief disorder (PGD) is a bereavement-specific syndrome that is defined as intense, prolonged yearning and preoccupation with thoughts of the deceased. PGD prevalence after the loss of a relative was 10% (95%CI 7-14) in the general population.Post-traumatic stress disorder (PTSD) is a mental health condition that is triggered by experiencing a terrifying event. Symptoms may include flashbacks, nightmares, and severe anxiety. The reported lifetime PTSD prevalence is 7% among adults in the general population. Admission and death in the hospital can be a traumatic and stressful experience for relatives, and is associated with an up to 50% risk of PGD and PTSD at 6 months. In the setting of ICU, several studies have reported that implementation of simple human interventions (information supports including written information on end-of-life care and pro-active communication strategy with systematic interviews with relatives), was associated with a lower risk of PTSD at 3 months (45% vs. 69%) and PGD at 6 months (21% vs 57%). Furthermore, it has been reported that offering the possibility of relatives to be present during nursing and medical care may be beneficial. In the out of hospital setting, offering the possibility for relative to be present during resuscitation was also associated with a reduction of PTSD at 3 months (15% vs 26%), which was confirmed at 1 year. The ED setting differs from the one of ICU mainly because exposition time to the dying process is shorter and healthcare workers are less used to manage end of life. Whether these strategies are beneficial for patients dying in the ED, where dying patients are older with more end- stage chronic diseases and shorter length of stay, remains unknown. The hypothesize of the study is that a multifaceted intervention, including pro-active communication strategy, visual supports, and offering the possibility to be present during nursing and medical care would decrease the risk of PGD in relatives of patients dying in the ED.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
924

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Jun 2025Jun 2027

First Submitted

Initial submission to the registry

December 5, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

June 4, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

December 5, 2024

Last Update Submit

August 5, 2025

Conditions

Keywords

Post-traumatic stress disorder (PTSD)prolonged grief disorder (PGD)

Outcome Measures

Primary Outcomes (1)

  • Prolonged Grief 13-item revised scale (PG-R-13)

    The PG-R-13 measures the new DSM-V criteria for prolonged grief: yearning, preoccupation, identity disruption, disbelief, avoidance, intense emotional pain, difficulty with reintegration, emotional numbness, feeling that life is meaningless and intense loneliness. The score ranges from 10-50 and a score of 30 or more defined the prolonged grief disorder.

    6 months after inclusion.

Secondary Outcomes (2)

  • Signs of PTSD assessed by the PCL-5 scale.

    3 months

  • signs of anxiety and depression HADS scale

    3 months

Other Outcomes (4)

  • signs of PTSD

    6 months

  • signs of anxiety

    6 months

  • signs of depression

    6 months

  • +1 more other outcomes

Study Arms (2)

Usual care

NO INTERVENTION

Multi-faceted Intervention

EXPERIMENTAL
Other: Multi-faceted Intervention

Interventions

The participant, i.e. relative, will receive the multifaceted intervention which include: a first meeting with the healthcare team including written information about palliative care for dying patients, information on possibility to participate in care, pro-active communication, and dedicated interview and brochure after the patient's death with possibility of psychological follow up.

Multi-faceted Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Relative of a patient, that is dying in the ED, defined by an anticipated life expectancy of less than 72H with previous do not resuscitate order or treatment withholding.
  • If several relative are present, participation to the trial will be offered in priority to the patient's trustworthy person, the relative most involved in the patient's care, the partner, a parent or child, another family member.
  • Age \>= 18 years
  • Agrees to be followed-up by phone interview at 3 and 6 months
  • Informed oral consent
  • Relative with health insurance (except AME).

You may not qualify if:

  • Relative who do not understand, read, or speak French
  • Relatives of organ donor patients (these relatives benefit from specific support and communication by the transplant coordination teams)
  • Inability to follow up
  • Participation in another intervention trial
  • Relative under legal protection (tutorship or curatorship)
  • Relative deprived of their liberty by a judicial or administrative decision
  • Relative physically unable to give his/her oral consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Department Hospital Pitié-Salpêtrière

Paris, Paris, 75013, France

RECRUITING

MeSH Terms

Conditions

Prolonged Grief DisorderStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental DisordersStress Disorders, Traumatic

Study Officials

  • Yonathan FREUND, PU-PH

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yonathan FREUND, PU-PH

CONTACT

Mélanie ROUSSEL, MD-PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 13, 2024

Study Start

June 4, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

August 6, 2025

Record last verified: 2025-08

Locations